OTC:ONTTF Oxford Nanopore Technologies (ONTTF) Stock Price, News & Analysis → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free ONTTF Stock Alerts $1.36 -0.09 (-5.86%) (As of 05/17/2024 03:27 PM ET) Add Compare Share Share Today's Range$1.37▼$1.4050-Day Range$1.18▼$1.8952-Week Range$1.13▼$3.52Volume209,434 shsAverage Volume39,129 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartHeadlinesStock AnalysisAnalyst ForecastsChartHeadlines Get Oxford Nanopore Technologies alerts: Email Address Ad Crypto 101 MediaThe Overlooked Retirement Asset You Probably Don’t Own4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. About Oxford Nanopore Technologies Stock (OTC:ONTTF)Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company operates in Life Science Research Tools and Covid Testing segments. It offers MinION, a portable device for DNA and RNA; GridION, a flexible and self-contained benchtop nanopore sequencer to run and analyse up to five MinION or Flongle flow cells; MinION Mk 1C, a nano pore-based sequencer with analysis software and connectivity for self-contained and portable sequencing; Flongle, an adapter for MinION or GridION that enables DNA sequencing or cDNA sequencing on smaller and single-use flow cells; and PromethION 2 Solo, a sequencer for two PromethION flow cells. The company also provides PromethION 2, a self-contained benchtop nanopore sequencer; PromethION 24, which provides single or multiple users with access to terabases of sequencing data; PromethION 48, a sequencing device with high-output flow cells; VolTRAX, an automated library prep for nanopore analyses; and Q-Line, a sequencing for applied applications, as well as products for SAR-Cov-2 testing. Its platform enables its customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies plc in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is headquartered in Oxford, the United Kingdom.Read More ONTTF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ONTTF Stock News HeadlinesApril 29, 2024 | msn.comDown 51% in 2024, is this UK growth stock a buy for my Stocks and Shares ISA?March 13, 2024 | lse.co.ukIP Group net asset value declines amid supply chain issues, inflationMarch 11, 2024 | businesswire.comOxford Nanopore Technologies and SeqOne Partner to Support Interpretation of Nanopore Sequencing in Clinical UseMarch 10, 2024 | finance.yahoo.comOxford Nanopore Technologies Non-Executive Chair Acquires 84% More StockMarch 7, 2024 | businesswire.comOxford Nanopore launches PromethION 2 Integrated into open early accessJanuary 19, 2024 | realmoney.thestreet.comOxford Nanopore price target lowered by 148 GBp at BerenbergJanuary 9, 2024 | msn.comBritain's Oxford Nanopore's shares sink after revenue warningNovember 28, 2023 | finance.yahoo.comThis Oxford Nanopore Technologies Insider Increased Their Holding By 56% Last YearOctober 31, 2023 | msn.comOxford Nanopore and Fabric Genomics launch software for paediatric patient careOctober 31, 2023 | uk.movies.yahoo.comApple showcases Oxford Nanopore in M3 launchOctober 26, 2023 | msn.comShould I buy Oxford Nanopore shares for 2024?October 24, 2023 | businesswire.comMayo Clinic and Oxford Nanopore announce collaboration to advance precision medicine for cancer and genetic disordersSeptember 8, 2023 | finance.yahoo.comOxford Nanopore Technologies First Half 2023 Earnings: Revenues Beat Expectations, EPS LagsJuly 17, 2023 | msn.comAre Oxford Nanopore shares set to soar?June 9, 2023 | businesswire.comOxford Nanopore Technologies and Geneyx Announce the First Scalable Software Solution to Advance the Future Clinical Use of Nanopore SequencingMay 5, 2023 | finance.yahoo.comMarket Participants Recognise Oxford Nanopore Technologies plc's (LON:ONT) RevenuesApril 19, 2023 | msn.comBerenberg Bank Reiterates Oxford Nanopore Technologies (LON:ONT) Buy RecommendationApril 14, 2023 | finance.yahoo.comOxford Nanopore and bioMérieux to Enter Into a Strategic Partnership Agreement to Develop Innovative Infectious Disease DiagnosticsApril 2, 2023 | fool.comOxford Nanopore Technologies Plc (LSE: ONT)March 20, 2023 | businesswire.comOxford Nanopore and 4bases Announce Collaboration to Combine Nanopore Sequencing Devices and 4bases Kits to Support Rapid, High-accuracy Analyses in Human and Cancer Genetics ...January 18, 2023 | marketwatch.comOxford Nanopore Technologies Expects Higher 2022 RevenueNovember 8, 2022 | finance.yahoo.comInsiders who bought into Oxford Nanopore Technologies plc (LON:ONT) earlier this year might wish they'd invested more as stock gained 7.8%October 12, 2022 | finance.yahoo.comInvestors are selling off Oxford Nanopore Technologies (LON:ONT), lack of profits no doubt contribute to shareholders one-year lossSeptember 15, 2022 | finance.yahoo.comHere's Why We're Not At All Concerned With Oxford Nanopore Technologies' (LON:ONT) Cash Burn SituationAugust 4, 2022 | marketwatch.comNanopore Technologies Market Size, Share, Global Trends, Major Key Players and Geographical Forecast Till 2029See More Headlines Receive ONTTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oxford Nanopore Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTC SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTC:ONTTF CUSIPN/A CIKN/A Webnanoporetech.com Phone44 84 5034 7900FaxN/AEmployees1,238Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesDr. Gurdial Singh Sanghera (Age 63)Co-Founder, CEO & Non-Executive Director Comp: $1.96MMr. Timothy Cowper (Age 59)COO & Director Comp: $1.11MDr. James Spike WillcocksChief Strategy Officer & DirectorProf. Hagan Bayley Ph.D.Co-Founder & Member of Technical Advisory BoardMr. Nicholas Patrick Keher (Age 42)CFO & Director Mr. Jordan HermanSenior VP & General CounselMr. John SchoellermanSenior Vice President of Corporate & Business DevelopmentMr. Richard ComptonSenior Vice President of Sales & Commercial OperationsMs. Sara Agee LeVice President of Global MarketingMs. Sarah LapworthSenior Vice President of Global Human ResourcesMore ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFView All Competitors ONTTF Stock Analysis - Frequently Asked Questions How have ONTTF shares performed in 2024? Oxford Nanopore Technologies' stock was trading at $2.60 at the start of the year. Since then, ONTTF stock has decreased by 47.5% and is now trading at $1.3650. View the best growth stocks for 2024 here. How do I buy shares of Oxford Nanopore Technologies? Shares of ONTTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTC:ONTTF) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Nanopore Technologies plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.